title: Development of a high throughput scintillation proximity assay for hepatitis C virus NS3 protease that reduces the proportion of competitive inhibitors identified.
abstract: A screening assay has been developed for hepatitis C virus (HCV) NS3 protease using the scintillation proximity assay (SPA) technology. The sequence of the peptide substrate used was taken from the site cleaved by the enzyme in the mature nonstructural protein of HCV. The peptide was biotinylated at the N-terminus and tritiated at the C-terminus so that a decrease in signal was detected as a result of enzyme activity. IC(50) values were calculated for the cleaved product, and it was shown that the value obtained was dependent on the substrate concentration used. The effect of substrate concentration on the inhibition of HCV NS3 protease was further highlighted in a mock screening assay, using colored natural product samples, in which the hit rate was altered by a change in substrate concentration. An increase in substrate concentration reduced the proportion of competitive inhibitors identified. This study highlighted the importance of optimizing the components used in SPA assays in order to obtain an assay format valid for high throughput screening.
authors.affiliation: Department of SPA Technology, Amersham Pharmacia Biotech UK Limited, Little Chalfont, Buckinghamshire, England. Anne.fowler@eu.apbiotech.com
authors.forename: A
authors.initials: A
authors.lastname: Fowler
authors.forename: M
authors.initials: M
authors.lastname: Price-Jones
authors.forename: K
authors.initials: K
authors.lastname: Hughes
authors.forename: J
authors.initials: J
authors.lastname: Anson
authors.forename: R
authors.initials: R
authors.lastname: Lingham
authors.forename: M
authors.initials: M
authors.lastname: Schulman
mesh_terms: D001667:Binding, Competitive; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D012588:Scintillation Counting / Q000379:methods*; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases
chemical_list: D004791:Enzyme Inhibitors; D017361:Viral Nonstructural Proteins; C084422:NS3 protein, hepatitis C virus; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases